UB Paderborn / Katalog / Suche / in CDI

Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

Gastroenterology (New York, N.Y. 1943), 2013-03, Vol.144 (3), p.560-569.e7

2013

Volltextzugriff (PDF)

Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study

Hepatology (Baltimore, Md.), 2013-07, Vol.58 (1), p.273-283

2013

Volltextzugriff (PDF)

rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis

Journal of autoimmunity, 2022-01, Vol.126, p.102775-102775, Article 102775

2022

Volltextzugriff (PDF)

Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis

PLoS genetics, 2018-12, Vol.14 (12), p.e1007833

2018

Volltextzugriff (PDF)

Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery

JHEP reports, 2024-01, Vol.6 (1), p.100931-100931, Article 100931

2024

Volltextzugriff (PDF)

Commentary on “Genome‐wide meta‐analysis identifies novel susceptibility loci for autoimmune hepatitis type 1”

Hepatology (Baltimore, Md.), 2022-09, Vol.76 (3), p.541-543

2022

Volltextzugriff (PDF)

Novel insights into autoimmune liver diseases provided by genome-wide association studies

Journal of autoimmunity, 2013-10, Vol.46, p.41-54

2013

Volltextzugriff (PDF)

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Science (American Association for the Advancement of Science), 2021-02, Vol.371 (6531), p.839-846

2021

Volltextzugriff (PDF)

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis

Scandinavian journal of gastroenterology, 2012-07, Vol.47 (7), p.820-826

2012

Volltextzugriff (PDF)

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

Nature genetics, 2011-04, Vol.43 (4), p.329-332

2011

Volltextzugriff (PDF)

Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers

Autoimmunity reviews, 2018-09, Vol.17 (9), p.854-865

2018

Volltextzugriff (PDF)

Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

Nature genetics, 2012-10, Vol.44 (10), p.1137-1141

2012

Volltextzugriff (PDF)

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom

Clinical gastroenterology and hepatology, 2019-06, Vol.17 (7), p.1379-1387.e3

2019

Volltextzugriff (PDF)

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System

Hepatology (Baltimore, Md.), 2019-05, Vol.69 (5), p.2120-2135

2019

Volltextzugriff (PDF)

Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom

Clinical gastroenterology and hepatology, 2021-04, Vol.19 (4), p.768-776.e10

2021

Volltextzugriff (PDF)

Letter: histology is relevant for risk stratification in primary biliary cholangitis

Alimentary pharmacology & therapeutics, 2020-01, Vol.51 (1), p.192-193

2020

Volltextzugriff (PDF)

Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury

ESMO open, 2017, Vol.2 (4), p.e000268, Article e000268

2017

Volltextzugriff (PDF)

Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581]

Journal of hepatology, 2023-04, Vol.78 (4), p.883-883

2023

Volltextzugriff (PDF)

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

The lancet. Gastroenterology & hepatology, 2017-10, Vol.2 (10), p.716-726

2017

Volltextzugriff (PDF)

Toward precision medicine in primary biliary cholangitis

Digestive and liver disease, 2016-08, Vol.48 (8), p.843-850

2016

Volltextzugriff (PDF)

The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort

Journal of hepatology, 2013-07, Vol.59 (1), p.67-73

2013

Volltextzugriff (PDF)

Primary biliary cirrhosis: Family, genes, and bugs

Clinical liver disease (Malden, Mass.), 2014-04, Vol.3 (4), p.69-73

Mells, George F.

2014

Volltextzugriff (PDF)

Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis

Hepatology communications, 2018-06, Vol.2 (6), p.683-692

2018

Volltextzugriff (PDF)

Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells

Hepatology communications, 2023-04, Vol.7 (4)

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study

rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis

Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis

Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery

Commentary on “Genome‐wide meta‐analysis identifies novel susceptibility loci for autoimmune hepatitis type 1”

Novel insights into autoimmune liver diseases provided by genome-wide association studies

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers

Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System

Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom

Letter: histology is relevant for risk stratification in primary biliary cholangitis

Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury

Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581]

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice

Toward precision medicine in primary biliary cholangitis

The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort

Primary biliary cirrhosis: Family, genes, and bugs

Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis

Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells

Suchergebnisse filtern